Dutasteride

Treatment of Benign Prostatic Hyperplasia (BPH)

Dutasteride is primarily prescribed to treat men with an enlarged prostate, a condition called benign prostatic hyperplasia (BPH). As the prostate gland grows, it can press on the urethra, leading to various urinary problems. This medication works to improve these symptoms and manage the condition over time.

Improving Urinary Symptoms

By helping to shrink the enlarged prostate, dutasteride can alleviate several common symptoms, including:

• A weak urine stream.
• Difficulty starting urination.
• The need to urinate frequently, especially at night.
• A feeling that the bladder is not completely empty.
• Urgent needs to urinate.

Reducing Long-Term Risks

In addition to symptom relief, dutasteride is used to lower the risk of complications associated with BPH. These include:

• Acute urinary retention: A sudden and painful inability to pass urine.
• Prostate surgery: Reducing the size of the prostate may decrease the likelihood that a surgical procedure will be necessary in the future.

Dutasteride may be prescribed alone or in combination with other medications to manage BPH symptoms more effectively. It is intended for use only by men with an enlarged prostate and is not approved for use in women or children.

Dutasteride belongs to a class of medications called 5-alpha reductase inhibitors. It works by blocking the action of an enzyme called 5-alpha reductase, which is responsible for converting the hormone testosterone into dihydrotestosterone (DHT).

DHT is the primary hormone that stimulates the growth of the prostate gland. In men with benign prostatic hyperplasia (BPH), the prostate becomes enlarged and can press against the urethra, leading to difficulty urinating and other urinary symptoms. By inhibiting the production of DHT, dutasteride helps to:

• Shrink the enlarged prostate gland over time.
• Improve the flow of urine.
• Reduce the risk of acute urinary retention (a sudden inability to urinate).
• Decrease the likelihood that prostate surgery will be needed.

Because this medication works by gradually shrinking the prostate tissue, it may take several months of treatment before a significant improvement in symptoms is noticed.

Common Side Effects

Dutasteride may cause side effects related to sexual function and breast tissue. Common side effects include:

• Difficulty getting or keeping an erection.
• Decreased desire for sex.
• Problems with ejaculation, such as a decrease in the amount of semen released.
• Breast enlargement or tenderness.

For some men, sexual side effects may continue after they stop taking dutasteride.

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Signs of a severe allergic reaction, including hives, skin rash, itching, or swelling of the face, tongue, or throat.
• Difficulty breathing or swallowing.
• Changes in the breasts, such as new lumps, pain, or nipple discharge.

Dutasteride may also be associated with an increased risk of developing high-grade prostate cancer, which is a more serious form of the disease.

Pregnancy and Handling Precautions

Dutasteride is not approved for use in women. The medication can be absorbed through the skin and may cause birth defects in a male fetus. Women who are pregnant or may become pregnant should avoid handling leaking capsules. If contact occurs, the area should be washed immediately with soap and water.

Prostate Cancer Risk

Clinical studies have shown that medications in this class, known as 5-alpha reductase inhibitors, may increase the risk of developing a more serious form of prostate cancer, called high-grade prostate cancer. Healthcare providers usually perform screenings to rule out prostate cancer before starting treatment and periodically thereafter.

Effect on PSA Levels

Dutasteride reduces the level of prostate-specific antigen (PSA) in the blood by approximately 50%. Because PSA tests are used to screen for prostate cancer, healthcare providers must adjust their interpretation of these results for patients taking this medication.

Blood Donation

To prevent the medication from being transferred to a pregnant woman through a blood transfusion, individuals should not donate blood while taking dutasteride or for at least six months after the last dose.

Breast Changes

Men taking dutasteride have reported changes in breast tissue, including enlargement, tenderness, lumps, or nipple discharge. These symptoms require evaluation by a healthcare professional.

Liver Impairment

Dutasteride is processed by the liver. Caution is necessary for individuals with liver disease, as the medication may remain in the system for an extended period.

Pregnancy Risks

Dutasteride is known to cause birth defects in male fetuses. It works by preventing the conversion of testosterone to dihydrotestosterone (DHT), which is necessary for the normal development of male sex organs. If a woman who is pregnant with a male fetus is exposed to the drug, it may cause the fetus's external genitalia to develop abnormally.

Handling Precautions

Because dutasteride can be absorbed through the skin, women who are pregnant or who may become pregnant should not handle dutasteride capsules. This is especially important if the capsules are cracked or leaking. If a woman comes into contact with the medication from a leaking capsule, the area should be washed immediately with soap and water.

Exposure Through Semen

Dutasteride is present in the semen of men taking the medication. It is not known if a male fetus could be harmed if a pregnant woman is exposed to the semen of a partner taking dutasteride. Healthcare providers may recommend using a condom if a sexual partner is pregnant or could become pregnant.

Breastfeeding

Dutasteride is not indicated for use in women. It is not known whether the drug passes into breast milk or if it could affect a nursing infant.

Available Forms

Dutasteride is available for oral use in the following forms:

• Soft gelatin capsules: These are liquid-filled capsules intended to be swallowed whole.
• Combination capsules: This medication is also available in a hard-shell capsule form that contains both dutasteride and tamsulosin hydrochloride.

It is important to swallow these capsules whole without crushing, chewing, or opening them. The liquid contents of the capsule may cause irritation to the mouth, lips, or throat if they come into direct contact with these areas.

FDA Approval and Indications

Dutasteride is approved by the U.S. Food and Drug Administration (FDA) for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is indicated to improve symptoms, reduce the risk of acute urinary retention, and reduce the need for BPH-related surgery. The medication is approved for use as a monotherapy or in combination with the alpha-blocker tamsulosin.

Safety Communications

The FDA has issued safety communications regarding the class of drugs known as 5-alpha reductase inhibitors (5-ARIs), which includes dutasteride. Clinical trial data indicated that while these drugs may decrease the overall risk of prostate cancer, they are associated with an increased risk of being diagnosed with high-grade prostate cancer, which is a more serious and faster-growing form of the disease.

The FDA required updates to the professional labeling for these drugs to reflect this risk. Healthcare providers are advised to perform regular prostate cancer screenings, such as digital rectal exams and prostate-specific antigen (PSA) tests, before and during treatment with dutasteride.

Usage Restrictions and Warnings

Dutasteride is not FDA-approved for the prevention of prostate cancer. It is also not approved for use in women or children. Because the medication can be absorbed through the skin and cause birth defects in a developing male fetus, the FDA-approved labeling warns that women who are pregnant or may become pregnant should not handle the capsules, especially if they are leaking.

How Dutasteride Affects Hair

Dutasteride belongs to a group of medicines called 5-alpha reductase inhibitors. It works by blocking the enzyme responsible for changing testosterone into dihydrotestosterone (DHT). DHT is a hormone that contributes to the shrinking of hair follicles in men with male pattern baldness, also known as androgenetic alopecia. By lowering DHT levels in the scalp, the medication may help slow hair loss or promote hair regrowth in some individuals.

Off-Label Status

It is important to note that while dutasteride is approved to treat symptoms of an enlarged prostate, it is not specifically approved for the treatment of hair loss in many regions, including the United States. When a doctor prescribes it for hair loss, it is considered an off-label use. Evidence regarding its long-term effectiveness and safety specifically for hair loss is more limited compared to medications officially approved for that purpose.

Important Safety Information

• Use in Men Only: This medication is intended for use by men only. It is not safe for use in women or children.
• Pregnancy Warning: Women who are pregnant or may become pregnant must not handle dutasteride capsules. The medication can be absorbed through the skin and may cause birth defects in a male fetus. If a woman comes into contact with a leaking capsule, the area should be washed immediately with soap and water.
• Treatment Duration: Results are not immediate and may take several months to become noticeable. If the medication is discontinued, any improvements in hair density or growth will likely disappear over time as the hormone levels return to their previous state.